How many institutions held PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in Q3 2023?

48 institutional investors reported PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share for Q3 2023. Use the holders table for investor-level position and value details.

Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Q: What does CUSIP 702712100 represent in this 13F holders report?

CUSIP 702712100 is the security identifier for PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 702712100

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 32,389,479
Total 13F value: $21,315,264
Share change: -977,471
SEC-reported price per share: $0.66
Number of holders: 48
Value change: -$689,693
Number of buys: 17
Number of sells: 18
Shares outstanding: 3,208,376

Security key

702712100

Report period

Q3 2023

Institutions

Top holders

PASG full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Passage BIO, Inc. SEC filings Passage BIO, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 702712100

Newer quarter: Q4 2025

Recent filing periods:

Q4 2025

Ownership snapshot

Top reported holders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Thomas Woiwode

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Jun 2023

3/4/5 13F Highest disclosed value: $9,530,263 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $9.53M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $9.53M

Versant Venture Management, LLC $4.67M

New Leaf Venture Partners, L.L.C. $2.35M

Erste Asset Management GmbH $2.03M

BML Capital Management, LLC $1.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Thomas Woiwode	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	— 24,000 shares	—	25 May 2023
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$9,530,263 10,124,576 shares	—	30 Jun 2023
Versant Venture Management, LLC	13F Company 13F	— denominator unverified	$4,668,631 4,959,769 shares	—	30 Jun 2023
New Leaf Venture Partners, L.L.C.	13F Company 13F	— denominator unverified	$2,348,047 2,497,922 shares	—	30 Jun 2023
Erste Asset Management GmbH	13F Company 13F	— denominator unverified	$2,031,813 2,160,800 shares	—	30 Jun 2023
BML Capital Management, LLC	13F Company 13F	— denominator unverified	$1,937,917 2,058,767 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

32,389,479

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

-5

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend